The wide spectrum of pulmonary vascular disorders in liver disease and
portal hypertension ranges from the hepatopulmonary syndrome characte
rized by intrapulmonary vascular dilatations, to pulmonary hypertensio
n (portopulmonary hypertension), in which pulmonary vascular resistanc
e is elevated, Since hepatopulmonary syndrome and portopulmonary hyper
tension have been reported in patients with nonhepatic portal hyperten
sion,the common factor that determines their development must be porta
l hypertension. The clinical presentations are very different, with ga
s exchange impairment in the hepatopulmonary syndrome and haemodynamic
failure in portopulmonary hypertension. The severity of hepatopulmona
ry syndrome stems to parallel the severity of liver failure, whereas n
o simple relationship has been identified between hepatic impairment a
nd the severity of portopulmonary hypertension. Resolution of hepatopu
lmonary syndrome is common after liver transplantation, which has an u
ncertain effect in portopulmonary hypertension. The pathophysiology of
both syndromes may involve vasoactive mediators and angiogenic factor
s.